The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Wealth Creation from the Commercialization of Genomics Science
Abstract
In this chapter, we provided a synopsis about the inception of the human genome sequencing initiative. The role of the Nobel Laureate (James D. Watson) in enabling this gigantic scientific venture to be accomplished cannot be overemphasized. The United States National Institute of Health and the U.S. Department of Energy characterized the thematic units of the sequencing efforts, which eventually led to wealth creation. We have predicted that in the next decade, wealth derived from genomic science could be concentrated in few commercial enterprises in the G8 nations and China. The intervention of the various international health and educational organizations are needed to eliminate global genomic disparities. The ethical legal, social, and financial implications of genomic research were also discussed. The enormous economic and medical benefits of genomics were outlined. Efforts were made to compare the diffusion of genomic scientific interventions in the progressive developing nations such as Brazil, Russia, India, China, and South Africa (BRICS) and the least-developing countries as Angola, Bangladesh, and the Republic of Benin, among others. The financial implications involved in implementing comprehensive genomic sciences in these least-developing nations were discussed.
Related Content
|
.
© 2023.
12 pages.
|
|
.
© 2023.
43 pages.
|
|
.
© 2023.
29 pages.
|
|
.
© 2023.
11 pages.
|
|
.
© 2023.
23 pages.
|
|
.
© 2023.
26 pages.
|
|
.
© 2023.
48 pages.
|
|
|